nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Hyperaemia—Carmustine—malignant glioma	0.0494	0.0572	CcSEcCtD
Hyoscyamine—Visual acuity reduced—Temozolomide—malignant glioma	0.0242	0.0281	CcSEcCtD
Hyoscyamine—Paranoia—Carmustine—malignant glioma	0.0219	0.0253	CcSEcCtD
Hyoscyamine—Stupor—Carmustine—malignant glioma	0.02	0.0231	CcSEcCtD
Hyoscyamine—Petechiae—Temozolomide—malignant glioma	0.0175	0.0203	CcSEcCtD
Hyoscyamine—Speech disorder—Carmustine—malignant glioma	0.0173	0.0201	CcSEcCtD
Hyoscyamine—Speech disorder—Temozolomide—malignant glioma	0.0167	0.0194	CcSEcCtD
Hyoscyamine—Leukocytosis—Carmustine—malignant glioma	0.0159	0.0184	CcSEcCtD
Hyoscyamine—Dexmethylphenidate—SLC6A3—malignant glioma	0.0152	0.238	CrCbGaD
Hyoscyamine—Methylphenidate—SLC6A3—malignant glioma	0.0152	0.238	CrCbGaD
Hyoscyamine—Injection site reaction—Carmustine—malignant glioma	0.0148	0.0172	CcSEcCtD
Hyoscyamine—Respiratory failure—Temozolomide—malignant glioma	0.0147	0.017	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Carmustine—malignant glioma	0.0144	0.0167	CcSEcCtD
Hyoscyamine—Skin exfoliation—Carmustine—malignant glioma	0.0142	0.0165	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Temozolomide—malignant glioma	0.0139	0.0161	CcSEcCtD
Hyoscyamine—Skin exfoliation—Temozolomide—malignant glioma	0.0138	0.0159	CcSEcCtD
Hyoscyamine—Coma—Carmustine—malignant glioma	0.0136	0.0158	CcSEcCtD
Hyoscyamine—Cyclopentolate—BCHE—malignant glioma	0.0135	0.21	CrCbGaD
Hyoscyamine—Dry eye—Temozolomide—malignant glioma	0.0133	0.0154	CcSEcCtD
Hyoscyamine—Swelling—Carmustine—malignant glioma	0.0123	0.0142	CcSEcCtD
Hyoscyamine—Eye pain—Carmustine—malignant glioma	0.012	0.0139	CcSEcCtD
Hyoscyamine—Eye pain—Temozolomide—malignant glioma	0.0116	0.0134	CcSEcCtD
Hyoscyamine—Cocaine—SLC6A3—malignant glioma	0.0115	0.18	CrCbGaD
Hyoscyamine—Amnesia—Carmustine—malignant glioma	0.0115	0.0133	CcSEcCtD
Hyoscyamine—Nasal congestion—Temozolomide—malignant glioma	0.0115	0.0133	CcSEcCtD
Hyoscyamine—Amnesia—Temozolomide—malignant glioma	0.0111	0.0129	CcSEcCtD
Hyoscyamine—Thirst—Temozolomide—malignant glioma	0.011	0.0127	CcSEcCtD
Hyoscyamine—Hyponatraemia—Carmustine—malignant glioma	0.0109	0.0126	CcSEcCtD
Hyoscyamine—Ataxia—Carmustine—malignant glioma	0.0102	0.0118	CcSEcCtD
Hyoscyamine—Hypokalaemia—Carmustine—malignant glioma	0.00985	0.0114	CcSEcCtD
Hyoscyamine—Ataxia—Temozolomide—malignant glioma	0.00983	0.0114	CcSEcCtD
Hyoscyamine—Dehydration—Temozolomide—malignant glioma	0.00973	0.0113	CcSEcCtD
Hyoscyamine—Dry skin—Temozolomide—malignant glioma	0.00959	0.0111	CcSEcCtD
Hyoscyamine—Hypokalaemia—Temozolomide—malignant glioma	0.00952	0.011	CcSEcCtD
Hyoscyamine—Dysphagia—Carmustine—malignant glioma	0.00935	0.0108	CcSEcCtD
Hyoscyamine—Abdominal distension—Temozolomide—malignant glioma	0.0091	0.0105	CcSEcCtD
Hyoscyamine—Dysphagia—Temozolomide—malignant glioma	0.00904	0.0105	CcSEcCtD
Hyoscyamine—Benzatropine—SLC6A3—malignant glioma	0.00865	0.135	CrCbGaD
Hyoscyamine—Dysuria—Temozolomide—malignant glioma	0.00845	0.00979	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Carmustine—malignant glioma	0.00844	0.00977	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Temozolomide—malignant glioma	0.00832	0.00964	CcSEcCtD
Hyoscyamine—Depression—Carmustine—malignant glioma	0.00832	0.00963	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Temozolomide—malignant glioma	0.00815	0.00944	CcSEcCtD
Hyoscyamine—Depression—Temozolomide—malignant glioma	0.00804	0.00931	CcSEcCtD
Hyoscyamine—Hallucination—Carmustine—malignant glioma	0.00745	0.00863	CcSEcCtD
Hyoscyamine—Hallucination—Temozolomide—malignant glioma	0.0072	0.00834	CcSEcCtD
Hyoscyamine—Flushing—Carmustine—malignant glioma	0.00695	0.00805	CcSEcCtD
Hyoscyamine—Flushing—Temozolomide—malignant glioma	0.00671	0.00778	CcSEcCtD
Hyoscyamine—Arrhythmia—Carmustine—malignant glioma	0.00669	0.00775	CcSEcCtD
Hyoscyamine—Mental disorder—Carmustine—malignant glioma	0.00656	0.0076	CcSEcCtD
Hyoscyamine—Erythema—Carmustine—malignant glioma	0.00652	0.00755	CcSEcCtD
Hyoscyamine—Mental disorder—Temozolomide—malignant glioma	0.00634	0.00734	CcSEcCtD
Hyoscyamine—Erythema—Temozolomide—malignant glioma	0.0063	0.0073	CcSEcCtD
Hyoscyamine—Dysgeusia—Temozolomide—malignant glioma	0.00617	0.00714	CcSEcCtD
Hyoscyamine—Vision blurred—Carmustine—malignant glioma	0.00614	0.00711	CcSEcCtD
Hyoscyamine—Agitation—Carmustine—malignant glioma	0.00599	0.00694	CcSEcCtD
Hyoscyamine—Vision blurred—Temozolomide—malignant glioma	0.00594	0.00688	CcSEcCtD
Hyoscyamine—Agitation—Temozolomide—malignant glioma	0.00579	0.0067	CcSEcCtD
Hyoscyamine—Angioedema—Temozolomide—malignant glioma	0.00575	0.00667	CcSEcCtD
Hyoscyamine—Vertigo—Temozolomide—malignant glioma	0.00566	0.00655	CcSEcCtD
Hyoscyamine—Convulsion—Carmustine—malignant glioma	0.00565	0.00654	CcSEcCtD
Hyoscyamine—Palpitations—Temozolomide—malignant glioma	0.00557	0.00645	CcSEcCtD
Hyoscyamine—Chest pain—Carmustine—malignant glioma	0.00555	0.00643	CcSEcCtD
Hyoscyamine—Anxiety—Carmustine—malignant glioma	0.00553	0.0064	CcSEcCtD
Hyoscyamine—Convulsion—Temozolomide—malignant glioma	0.00546	0.00632	CcSEcCtD
Hyoscyamine—Confusional state—Carmustine—malignant glioma	0.00536	0.00621	CcSEcCtD
Hyoscyamine—Anxiety—Temozolomide—malignant glioma	0.00534	0.00619	CcSEcCtD
Hyoscyamine—Oedema—Carmustine—malignant glioma	0.00532	0.00616	CcSEcCtD
Hyoscyamine—Dry mouth—Temozolomide—malignant glioma	0.00524	0.00607	CcSEcCtD
Hyoscyamine—Tachycardia—Carmustine—malignant glioma	0.00519	0.00601	CcSEcCtD
Hyoscyamine—Confusional state—Temozolomide—malignant glioma	0.00518	0.006	CcSEcCtD
Hyoscyamine—Oedema—Temozolomide—malignant glioma	0.00514	0.00595	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Temozolomide—malignant glioma	0.00514	0.00595	CcSEcCtD
Hyoscyamine—Hypotension—Carmustine—malignant glioma	0.00497	0.00576	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Temozolomide—malignant glioma	0.00497	0.00576	CcSEcCtD
Hyoscyamine—Insomnia—Carmustine—malignant glioma	0.00481	0.00557	CcSEcCtD
Hyoscyamine—Dyspnoea—Carmustine—malignant glioma	0.00474	0.00549	CcSEcCtD
Hyoscyamine—Somnolence—Carmustine—malignant glioma	0.00473	0.00548	CcSEcCtD
Hyoscyamine—Insomnia—Temozolomide—malignant glioma	0.00465	0.00539	CcSEcCtD
Hyoscyamine—Dyspnoea—Temozolomide—malignant glioma	0.00458	0.00531	CcSEcCtD
Hyoscyamine—Somnolence—Temozolomide—malignant glioma	0.00457	0.00529	CcSEcCtD
Hyoscyamine—Pain—Carmustine—malignant glioma	0.00455	0.00527	CcSEcCtD
Hyoscyamine—Constipation—Carmustine—malignant glioma	0.00455	0.00527	CcSEcCtD
Hyoscyamine—Dyspepsia—Temozolomide—malignant glioma	0.00452	0.00524	CcSEcCtD
Hyoscyamine—Fatigue—Temozolomide—malignant glioma	0.00443	0.00513	CcSEcCtD
Hyoscyamine—Constipation—Temozolomide—malignant glioma	0.0044	0.00509	CcSEcCtD
Hyoscyamine—Pain—Temozolomide—malignant glioma	0.0044	0.00509	CcSEcCtD
Hyoscyamine—Feeling abnormal—Carmustine—malignant glioma	0.00438	0.00508	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Carmustine—malignant glioma	0.00435	0.00504	CcSEcCtD
Hyoscyamine—Feeling abnormal—Temozolomide—malignant glioma	0.00424	0.00491	CcSEcCtD
Hyoscyamine—Abdominal pain—Carmustine—malignant glioma	0.0042	0.00487	CcSEcCtD
Hyoscyamine—Body temperature increased—Carmustine—malignant glioma	0.0042	0.00487	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Temozolomide—malignant glioma	0.0042	0.00487	CcSEcCtD
Hyoscyamine—Urticaria—Temozolomide—malignant glioma	0.00408	0.00473	CcSEcCtD
Hyoscyamine—Abdominal pain—Temozolomide—malignant glioma	0.00406	0.00471	CcSEcCtD
Hyoscyamine—Body temperature increased—Temozolomide—malignant glioma	0.00406	0.00471	CcSEcCtD
Hyoscyamine—Hypersensitivity—Carmustine—malignant glioma	0.00392	0.00454	CcSEcCtD
Hyoscyamine—Asthenia—Carmustine—malignant glioma	0.00382	0.00442	CcSEcCtD
Hyoscyamine—Hypersensitivity—Temozolomide—malignant glioma	0.00379	0.00439	CcSEcCtD
Hyoscyamine—Asthenia—Temozolomide—malignant glioma	0.00369	0.00427	CcSEcCtD
Hyoscyamine—Diarrhoea—Carmustine—malignant glioma	0.00364	0.00422	CcSEcCtD
Hyoscyamine—Pruritus—Temozolomide—malignant glioma	0.00364	0.00421	CcSEcCtD
Hyoscyamine—Dizziness—Carmustine—malignant glioma	0.00352	0.00407	CcSEcCtD
Hyoscyamine—Diarrhoea—Temozolomide—malignant glioma	0.00352	0.00407	CcSEcCtD
Hyoscyamine—Dizziness—Temozolomide—malignant glioma	0.0034	0.00394	CcSEcCtD
Hyoscyamine—Vomiting—Carmustine—malignant glioma	0.00338	0.00392	CcSEcCtD
Hyoscyamine—Rash—Carmustine—malignant glioma	0.00335	0.00388	CcSEcCtD
Hyoscyamine—Dermatitis—Carmustine—malignant glioma	0.00335	0.00388	CcSEcCtD
Hyoscyamine—Headache—Carmustine—malignant glioma	0.00333	0.00386	CcSEcCtD
Hyoscyamine—Vomiting—Temozolomide—malignant glioma	0.00327	0.00379	CcSEcCtD
Hyoscyamine—Rash—Temozolomide—malignant glioma	0.00324	0.00375	CcSEcCtD
Hyoscyamine—Dermatitis—Temozolomide—malignant glioma	0.00324	0.00375	CcSEcCtD
Hyoscyamine—Headache—Temozolomide—malignant glioma	0.00322	0.00373	CcSEcCtD
Hyoscyamine—Nausea—Carmustine—malignant glioma	0.00316	0.00366	CcSEcCtD
Hyoscyamine—Nausea—Temozolomide—malignant glioma	0.00305	0.00354	CcSEcCtD
Hyoscyamine—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	4.51e-05	0.000621	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GSTP1—malignant glioma	4.49e-05	0.000618	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—F2—malignant glioma	4.49e-05	0.000618	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PDGFB—malignant glioma	4.41e-05	0.000608	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FGFR1—malignant glioma	4.39e-05	0.000605	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT2—malignant glioma	4.38e-05	0.000604	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT2—malignant glioma	4.37e-05	0.000602	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CAT—malignant glioma	4.37e-05	0.000602	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CG—malignant glioma	4.35e-05	0.000599	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CG—malignant glioma	4.34e-05	0.000597	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	4.33e-05	0.000596	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HIF1A—malignant glioma	4.33e-05	0.000596	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	4.29e-05	0.000591	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PTPN11—malignant glioma	4.27e-05	0.000589	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PTPN11—malignant glioma	4.26e-05	0.000587	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH2—malignant glioma	4.24e-05	0.000585	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH2—malignant glioma	4.23e-05	0.000583	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	4.22e-05	0.000581	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CD—malignant glioma	4.21e-05	0.00058	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CD—malignant glioma	4.2e-05	0.000578	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	4.19e-05	0.000577	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CAV1—malignant glioma	4.18e-05	0.000576	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	4.16e-05	0.000572	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KNG1—malignant glioma	4.15e-05	0.000572	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KNG1—malignant glioma	4.14e-05	0.00057	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KDR—malignant glioma	4.14e-05	0.00057	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NCOR1—malignant glioma	4.13e-05	0.000568	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KNG1—malignant glioma	4.1e-05	0.000565	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—F2—malignant glioma	3.98e-05	0.000548	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FN1—malignant glioma	3.98e-05	0.000548	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT2—malignant glioma	3.98e-05	0.000548	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT2—malignant glioma	3.97e-05	0.000546	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NTRK1—malignant glioma	3.96e-05	0.000545	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NTRK1—malignant glioma	3.95e-05	0.000544	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—BAD—malignant glioma	3.93e-05	0.000542	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT2—malignant glioma	3.93e-05	0.000541	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NTRK1—malignant glioma	3.91e-05	0.000538	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOTCH1—malignant glioma	3.9e-05	0.000537	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CD—malignant glioma	3.82e-05	0.000527	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CD80—malignant glioma	3.82e-05	0.000526	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	3.81e-05	0.000525	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APC—malignant glioma	3.81e-05	0.000525	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CG—malignant glioma	3.81e-05	0.000525	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	3.77e-05	0.00052	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGF—malignant glioma	3.77e-05	0.000519	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTPN11—malignant glioma	3.74e-05	0.000516	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP3—malignant glioma	3.68e-05	0.000507	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	3.67e-05	0.000506	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP3—malignant glioma	3.67e-05	0.000505	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	3.66e-05	0.000504	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	3.65e-05	0.000502	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	3.64e-05	0.000501	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP3—malignant glioma	3.63e-05	0.0005	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	3.62e-05	0.000499	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	3.6e-05	0.000496	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—BRAF—malignant glioma	3.58e-05	0.000493	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTK2—malignant glioma	3.54e-05	0.000488	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTK2—malignant glioma	3.53e-05	0.000486	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	3.53e-05	0.000486	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	3.52e-05	0.000484	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTK2—malignant glioma	3.5e-05	0.000482	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT2—malignant glioma	3.49e-05	0.00048	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	3.48e-05	0.00048	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HES1—malignant glioma	3.48e-05	0.000479	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—malignant glioma	3.47e-05	0.000478	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HES1—malignant glioma	3.47e-05	0.000478	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NCOR1—malignant glioma	3.46e-05	0.000477	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NCOR1—malignant glioma	3.45e-05	0.000475	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HES1—malignant glioma	3.44e-05	0.000473	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	3.42e-05	0.00047	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—RAF1—malignant glioma	3.41e-05	0.00047	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—RAF1—malignant glioma	3.4e-05	0.000469	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2—malignant glioma	3.37e-05	0.000464	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	3.37e-05	0.000464	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CAV1—malignant glioma	3.36e-05	0.000463	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2—malignant glioma	3.36e-05	0.000463	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CD—malignant glioma	3.35e-05	0.000461	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	3.33e-05	0.000459	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	3.33e-05	0.000458	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	3.32e-05	0.000458	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—malignant glioma	3.32e-05	0.000457	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	3.31e-05	0.000456	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	3.3e-05	0.000455	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	3.29e-05	0.000453	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—KRAS—malignant glioma	3.28e-05	0.000452	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	3.27e-05	0.000451	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SPP1—malignant glioma	3.22e-05	0.000443	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FGF2—malignant glioma	3.21e-05	0.000442	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SPP1—malignant glioma	3.21e-05	0.000442	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	3.2e-05	0.000441	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	3.19e-05	0.00044	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SPP1—malignant glioma	3.18e-05	0.000437	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	3.16e-05	0.000435	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—malignant glioma	3.06e-05	0.000422	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—malignant glioma	3.06e-05	0.000422	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—malignant glioma	3.05e-05	0.00042	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TERT—malignant glioma	3.05e-05	0.00042	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TERT—malignant glioma	3.04e-05	0.000419	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—malignant glioma	3.02e-05	0.000416	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—malignant glioma	3.01e-05	0.000415	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TERT—malignant glioma	3.01e-05	0.000415	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MDM2—malignant glioma	3e-05	0.000413	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RAF1—malignant glioma	2.99e-05	0.000412	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PDGFB—malignant glioma	2.98e-05	0.00041	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PDGFB—malignant glioma	2.97e-05	0.000409	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGFR1—malignant glioma	2.96e-05	0.000408	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ERBB2—malignant glioma	2.96e-05	0.000408	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—malignant glioma	2.96e-05	0.000407	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGFR1—malignant glioma	2.95e-05	0.000407	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	2.94e-05	0.000405	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	2.92e-05	0.000403	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CB—malignant glioma	2.92e-05	0.000402	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—malignant glioma	2.92e-05	0.000402	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—malignant glioma	2.91e-05	0.0004	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	2.88e-05	0.000397	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CAV1—malignant glioma	2.82e-05	0.000389	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CAV1—malignant glioma	2.81e-05	0.000387	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—malignant glioma	2.81e-05	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—malignant glioma	2.79e-05	0.000384	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CAV1—malignant glioma	2.78e-05	0.000384	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—malignant glioma	2.78e-05	0.000383	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—malignant glioma	2.75e-05	0.000379	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—malignant glioma	2.71e-05	0.000373	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CD—malignant glioma	2.69e-05	0.000371	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—malignant glioma	2.69e-05	0.00037	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—F2—malignant glioma	2.68e-05	0.00037	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FN1—malignant glioma	2.68e-05	0.00037	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—malignant glioma	2.68e-05	0.000369	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FN1—malignant glioma	2.68e-05	0.000369	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—F2—malignant glioma	2.68e-05	0.000369	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BAD—malignant glioma	2.65e-05	0.000365	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—F2—malignant glioma	2.65e-05	0.000365	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FN1—malignant glioma	2.65e-05	0.000365	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BAD—malignant glioma	2.64e-05	0.000364	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	2.63e-05	0.000362	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	2.62e-05	0.000361	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BAD—malignant glioma	2.62e-05	0.000361	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	2.59e-05	0.000357	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CD80—malignant glioma	2.57e-05	0.000355	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APC—malignant glioma	2.57e-05	0.000354	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	2.57e-05	0.000354	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CD80—malignant glioma	2.57e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	2.56e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APC—malignant glioma	2.56e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CD80—malignant glioma	2.54e-05	0.00035	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGF—malignant glioma	2.54e-05	0.00035	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—malignant glioma	2.54e-05	0.00035	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APC—malignant glioma	2.54e-05	0.000349	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	2.54e-05	0.000349	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGF—malignant glioma	2.53e-05	0.000349	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTPN11—malignant glioma	2.52e-05	0.000348	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTEN—malignant glioma	2.52e-05	0.000348	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTPN11—malignant glioma	2.52e-05	0.000347	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGF—malignant glioma	2.51e-05	0.000345	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	2.49e-05	0.000343	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—malignant glioma	2.46e-05	0.000339	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BRAF—malignant glioma	2.42e-05	0.000333	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BRAF—malignant glioma	2.41e-05	0.000332	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BRAF—malignant glioma	2.38e-05	0.000328	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT2—malignant glioma	2.35e-05	0.000324	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CB—malignant glioma	2.35e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT2—malignant glioma	2.34e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—malignant glioma	2.34e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—malignant glioma	2.33e-05	0.000321	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—malignant glioma	2.33e-05	0.00032	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT2—malignant glioma	2.32e-05	0.00032	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	2.31e-05	0.000318	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—malignant glioma	2.28e-05	0.000314	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	2.26e-05	0.000311	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—malignant glioma	2.26e-05	0.000311	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	2.25e-05	0.00031	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	2.24e-05	0.000308	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	2.23e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	2.23e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	2.21e-05	0.000305	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	2.21e-05	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—KRAS—malignant glioma	2.2e-05	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	2.18e-05	0.000301	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGF2—malignant glioma	2.16e-05	0.000298	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGF2—malignant glioma	2.16e-05	0.000297	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGF2—malignant glioma	2.13e-05	0.000294	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—malignant glioma	2.1e-05	0.000289	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—malignant glioma	2.05e-05	0.000282	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	2.03e-05	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTEN—malignant glioma	2.03e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	2.03e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MDM2—malignant glioma	2.02e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MDM2—malignant glioma	2.02e-05	0.000278	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RAF1—malignant glioma	2.02e-05	0.000278	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RAF1—malignant glioma	2.01e-05	0.000277	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	2.01e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MDM2—malignant glioma	2e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	2e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RAF1—malignant glioma	1.99e-05	0.000274	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	1.99e-05	0.000274	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	1.97e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	1.97e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	1.96e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	1.94e-05	0.000268	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KRAS—malignant glioma	1.94e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	1.89e-05	0.000261	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	1.89e-05	0.00026	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	1.87e-05	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	1.83e-05	0.000252	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	1.82e-05	0.000251	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—malignant glioma	1.81e-05	0.000249	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—malignant glioma	1.81e-05	0.000249	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—malignant glioma	1.81e-05	0.000249	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	1.8e-05	0.000248	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—malignant glioma	1.8e-05	0.000248	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—malignant glioma	1.79e-05	0.000246	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—malignant glioma	1.78e-05	0.000246	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	1.78e-05	0.000245	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TP53—malignant glioma	1.72e-05	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—malignant glioma	1.71e-05	0.000236	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—malignant glioma	1.71e-05	0.000235	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTEN—malignant glioma	1.7e-05	0.000234	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTEN—malignant glioma	1.7e-05	0.000234	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—malignant glioma	1.69e-05	0.000233	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTEN—malignant glioma	1.68e-05	0.000231	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	1.66e-05	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	1.65e-05	0.000228	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	1.64e-05	0.000226	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	1.54e-05	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	1.53e-05	0.000211	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—malignant glioma	1.52e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	1.52e-05	0.000209	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—malignant glioma	1.52e-05	0.000209	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—malignant glioma	1.5e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—malignant glioma	1.45e-05	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—malignant glioma	1.43e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—malignant glioma	1.41e-05	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—malignant glioma	1.41e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—malignant glioma	1.4e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—malignant glioma	1.38e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—malignant glioma	1.38e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.37e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KRAS—malignant glioma	1.31e-05	0.00018	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KRAS—malignant glioma	1.3e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.29e-05	0.000178	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.2e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.2e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.18e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—malignant glioma	1.17e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TP53—malignant glioma	1.16e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TP53—malignant glioma	1.16e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.15e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—malignant glioma	9.8e-06	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—malignant glioma	9.77e-06	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—malignant glioma	9.68e-06	0.000133	CbGpPWpGaD
